This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the management of diabetes. The contract has a ceiling value of $1,591.36 and is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2025. There is no set-aside designation for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,618.58, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $9,746.97 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,938.43, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. The contract is not set-aside and was awarded on April 10, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a ceiling value of $1,375.62 and is a firm fixed-price delivery order with a completion date of June 30, 2025. The contract is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $5,186.41 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $3,866.40 and a completion date of June 10, 2025. This delivery order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,120.18, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,242.88 and a period of performance through May 15, 2025. The contract is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $12,017.48 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...